Annual report
7730.TEDINET S100UUGP
Period2023-09-01 → 2024-08-31
Filed2024-11-26
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Amended by S100UVZO (2024-12-03).
Key figures · 148
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥28.5bn | 2023-09-01 → 2024-08-31 | Cons. | Net sales |
| Revenue | ¥24.5bn | 2022-09-01 → 2023-08-31 | Cons. | Net sales |
| Revenue | ¥20.4bn | 2021-09-01 → 2022-08-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥17.2bn | 2020-09-01 → 2021-08-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥15.2bn | 2019-09-01 → 2020-08-31d | Cons. | Net sales (5-year summary) |
| Operating income | ¥8.4bn | 2023-09-01 → 2024-08-31 | Cons. | Operating income |
| Operating income | ¥7.2bn | 2022-09-01 → 2023-08-31 | Cons. | Operating income |
| Ordinary income | ¥8.5bn | 2023-09-01 → 2024-08-31 | Cons. | Ordinary income |
| Ordinary income | ¥8.0bn | 2022-09-01 → 2023-08-31 | Cons. | Ordinary income |
| Ordinary income | ¥7.5bn | 2021-09-01 → 2022-08-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥5.7bn | 2020-09-01 → 2021-08-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥4.4bn | 2019-09-01 → 2020-08-31d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥8.4bn | 2023-09-01 → 2024-08-31 | Cons. | Income before income taxes |
| Profit before tax | ¥8.0bn | 2022-09-01 → 2023-08-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥6.3bn | 2023-09-01 → 2024-08-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥6.0bn | 2022-09-01 → 2023-08-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥5.3bn | 2021-09-01 → 2022-08-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥4.3bn | 2020-09-01 → 2021-08-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥3.3bn | 2019-09-01 → 2020-08-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥6.3bn | 2023-09-01 → 2024-08-31 | Cons. | Profit loss |
| Net income | ¥6.0bn | 2022-09-01 → 2023-08-31 | Cons. | Profit loss |
| Total assets | ¥57.2bn | at 2024-08-31 | Cons. | Assets |
| Total assets | ¥55.0bn | at 2023-08-31 | Cons. | Assets |
| Total assets | ¥50.1bn | at 2022-08-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥42.7bn | at 2021-08-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥39.3bn | at 2020-08-31d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥4.8bn | at 2024-08-31 | Cons. | Liabilities |
| Total liabilities | ¥5.1bn | at 2023-08-31 | Cons. | Liabilities |
| Net assets / equity | ¥52.3bn | at 2024-08-31 | Cons. | Net assets |
| Net assets / equity | ¥49.8bn | at 2023-08-31 | Cons. | Net assets |
| Net assets / equity | ¥45.4bn | at 2022-08-31d | Cons. | Net assets |
| Net assets / equity | ¥39.2bn | at 2021-08-31d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥36.6bn | at 2020-08-31d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥21.6bn | at 2024-08-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥25.4bn | at 2023-08-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥21.0bn | at 2024-08-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥23.8bn | at 2023-08-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥22.1bn | at 2022-08-31d | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥18.1bn | at 2021-08-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥17.0bn | at 2020-08-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥7.8bn | 2023-09-01 → 2024-08-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥8.0bn | 2022-09-01 → 2023-08-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥6.6bn | 2021-09-01 → 2022-08-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥6.4bn | 2020-09-01 → 2021-08-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥1.9bn | 2019-09-01 → 2020-08-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥6.6bn | 2023-09-01 → 2024-08-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥4.0bn | 2022-09-01 → 2023-08-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥2.2bn | 2021-09-01 → 2022-08-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥3.4bn | 2020-09-01 → 2021-08-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥38m | 2019-09-01 → 2020-08-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥3.7bn | 2023-09-01 → 2024-08-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥3.3bn | 2022-09-01 → 2023-08-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥2.4bn | 2021-09-01 → 2022-08-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥2.2bn | 2020-09-01 → 2021-08-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥2.1bn | 2019-09-01 → 2020-08-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥63.82 | 2023-09-01 → 2024-08-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥60.46 | 2022-09-01 → 2023-08-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥53.75 | 2021-09-01 → 2022-08-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥43.6 | 2020-09-01 → 2021-08-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥33.83 | 2019-09-01 → 2020-08-31d | Cons. | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥531.18 | at 2024-08-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥505.88 | at 2023-08-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥461.41 | at 2022-08-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥398.29 | at 2021-08-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥371.51 | at 2020-08-31d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 91.5% | at 2024-08-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 90.6% | at 2023-08-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 90.6% | at 2022-08-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 91.8% | at 2021-08-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 93.1% | at 2020-08-31d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 12.3% | 2023-09-01 → 2024-08-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 12.5% | 2022-09-01 → 2023-08-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 12.5% | 2021-09-01 → 2022-08-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 11.3% | 2020-09-01 → 2021-08-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 9.3% | 2019-09-01 → 2020-08-31d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 4,154 | at 2024-08-31 | Cons. | Number of employees |
| Employees | 3,685 | at 2023-08-31 | Cons. | Number of employees |
| Employees | 3,417 | at 2022-08-31d | Cons. | Number of employees |
| Employees | 3,313 | at 2021-08-31d | Cons. | Number of employees |
| Employees | 3,812 | at 2020-08-31d | Cons. | Number of employees |
| Revenue | ¥24.5bn | 2023-09-01 → 2024-08-31 | Standalone | Net sales |
| Revenue | ¥21.3bn | 2022-09-01 → 2023-08-31 | Standalone | Net sales |
| Revenue | ¥17.6bn | 2021-09-01 → 2022-08-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥14.8bn | 2020-09-01 → 2021-08-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥13.8bn | 2019-09-01 → 2020-08-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥7.2bn | 2023-09-01 → 2024-08-31 | Standalone | Operating income |
| Operating income | ¥5.4bn | 2022-09-01 → 2023-08-31 | Standalone | Operating income |
| Ordinary income | ¥7.4bn | 2023-09-01 → 2024-08-31 | Standalone | Ordinary income |
| Ordinary income | ¥6.2bn | 2022-09-01 → 2023-08-31 | Standalone | Ordinary income |
| Ordinary income | ¥7.5bn | 2021-09-01 → 2022-08-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥4.7bn | 2020-09-01 → 2021-08-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥4.2bn | 2019-09-01 → 2020-08-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥7.3bn | 2023-09-01 → 2024-08-31 | Standalone | Income before income taxes |
| Profit before tax | ¥6.3bn | 2022-09-01 → 2023-08-31 | Standalone | Income before income taxes |
| Net income | ¥5.4bn | 2023-09-01 → 2024-08-31 | Standalone | Profit loss |
| Net income | ¥4.5bn | 2022-09-01 → 2023-08-31 | Standalone | Profit loss |
| Net income | ¥5.5bn | 2021-09-01 → 2022-08-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥3.4bn | 2020-09-01 → 2021-08-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥3.4bn | 2019-09-01 → 2020-08-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥44.7bn | at 2024-08-31 | Standalone | Assets |
| Total assets | ¥43.5bn | at 2023-08-31 | Standalone | Assets |
| Total assets | ¥41.3bn | at 2022-08-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥37.2bn | at 2021-08-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥35.3bn | at 2020-08-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥3.9bn | at 2024-08-31 | Standalone | Liabilities |
| Total liabilities | ¥4.5bn | at 2023-08-31 | Standalone | Liabilities |
| Net assets / equity | ¥40.8bn | at 2024-08-31 | Standalone | Net assets |
| Net assets / equity | ¥39.0bn | at 2023-08-31 | Standalone | Net assets |
| Net assets / equity | ¥37.5bn | at 2022-08-31d | Standalone | Net assets |
| Net assets / equity | ¥34.4bn | at 2021-08-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥33.2bn | at 2020-08-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥11.3bn | at 2024-08-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥17.5bn | at 2023-08-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥54.78 | 2023-09-01 → 2024-08-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥45.69 | 2022-09-01 → 2023-08-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥55.9 | 2021-09-01 → 2022-08-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥34.98 | 2020-09-01 → 2021-08-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥34.31 | 2019-09-01 → 2020-08-31d | Standalone | Basic earnings loss per share (5-year summary) |
| Dividend per share | ¥39 | 2023-09-01 → 2024-08-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥35 | 2022-09-01 → 2023-08-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥30 | 2021-09-01 → 2022-08-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥23 | 2020-09-01 → 2021-08-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥22 | 2019-09-01 → 2020-08-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥414.33 | at 2024-08-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥396.29 | at 2023-08-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥381.33 | at 2022-08-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥349.63 | at 2021-08-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥337.38 | at 2020-08-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 91.3% | at 2024-08-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 89.7% | at 2023-08-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 90.9% | at 2022-08-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 92.4% | at 2021-08-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 94.1% | at 2020-08-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 13.5% | 2023-09-01 → 2024-08-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 11.8% | 2022-09-01 → 2023-08-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 15.3% | 2021-09-01 → 2022-08-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 10.2% | 2020-09-01 → 2021-08-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 10.3% | 2019-09-01 → 2020-08-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 107,003,277 | at 2024-08-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 106,981,502 | at 2023-08-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 106,911,000 | at 2022-08-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 106,911,000 | at 2021-08-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 106,911,000 | at 2020-08-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 403 | at 2024-08-31 | Standalone | Number of employees |
| Employees | 366 | at 2023-08-31 | Standalone | Number of employees |
| Employees | 350 | at 2022-08-31d | Standalone | Number of employees |
| Employees | 333 | at 2021-08-31d | Standalone | Number of employees |
| Employees | 320 | at 2020-08-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 46
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2023-09-01 → 2024-08-31 | ¥0 |
| Reconciling Itemsreconciling | revenue intersegment | 2023-09-01 → 2024-08-31 | ¥0 |
| Dental Related Productsreportable segment | depreciation | 2023-09-01 → 2024-08-31 | ¥1.0bn |
| Dental Related Productsreportable segment | employees | at 2024-08-31 | 1139 pure |
| Dental Related Productsreportable segment | revenue | 2023-09-01 → 2024-08-31 | ¥10.1bn |
| Dental Related Productsreportable segment | revenue external | 2023-09-01 → 2024-08-31 | ¥10.1bn |
| Dental Related Productsreportable segment | segment profit | 2023-09-01 → 2024-08-31 | ¥1.9bn |
| Eyeless Needle Related Productsreportable segment | depreciation | 2023-09-01 → 2024-08-31 | ¥776m |
| Eyeless Needle Related Productsreportable segment | employees | at 2024-08-31 | 1765 pure |
| Eyeless Needle Related Productsreportable segment | revenue | 2023-09-01 → 2024-08-31 | ¥10.2bn |
| Eyeless Needle Related Productsreportable segment | revenue external | 2023-09-01 → 2024-08-31 | ¥10.2bn |
| Eyeless Needle Related Productsreportable segment | revenue intersegment | 2023-09-01 → 2024-08-31 | ¥0 |
| Eyeless Needle Related Productsreportable segment | segment profit | 2023-09-01 → 2024-08-31 | ¥3.9bn |
| Surgel Related Productsreportable segment | depreciation | 2023-09-01 → 2024-08-31 | ¥484m |
| Surgel Related Productsreportable segment | employees | at 2024-08-31 | 764 pure |
| Surgel Related Productsreportable segment | revenue | 2023-09-01 → 2024-08-31 | ¥8.2bn |
| Surgel Related Productsreportable segment | revenue external | 2023-09-01 → 2024-08-31 | ¥8.2bn |
| Surgel Related Productsreportable segment | segment profit | 2023-09-01 → 2024-08-31 | ¥2.6bn |
| —segment total | depreciation | 2023-09-01 → 2024-08-31 | ¥2.3bn |
| —segment total | revenue | 2023-09-01 → 2024-08-31 | ¥28.5bn |
| —segment total | revenue external | 2023-09-01 → 2024-08-31 | ¥28.5bn |
| —segment total | revenue intersegment | 2023-09-01 → 2024-08-31 | ¥0 |
| —segment total | segment profit | 2023-09-01 → 2024-08-31 | ¥8.4bn |
| Reconciling Itemsreconciling | revenue | 2022-09-01 → 2023-08-31 | −¥1m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-09-01 → 2023-08-31 | −¥1m |
| Dental Related Productsreportable segment | depreciation | 2022-09-01 → 2023-08-31 | ¥818m |
| Dental Related Productsreportable segment | revenue | 2022-09-01 → 2023-08-31 | ¥9.1bn |
| Dental Related Productsreportable segment | revenue external | 2022-09-01 → 2023-08-31 | ¥9.1bn |
| Dental Related Productsreportable segment | segment profit | 2022-09-01 → 2023-08-31 | ¥2.3bn |
| Eyeless Needle Related Productsreportable segment | depreciation | 2022-09-01 → 2023-08-31 | ¥709m |
| Eyeless Needle Related Productsreportable segment | revenue | 2022-09-01 → 2023-08-31 | ¥8.6bn |
| Eyeless Needle Related Productsreportable segment | revenue external | 2022-09-01 → 2023-08-31 | ¥8.6bn |
| Eyeless Needle Related Productsreportable segment | revenue intersegment | 2022-09-01 → 2023-08-31 | ¥1m |
| Eyeless Needle Related Productsreportable segment | segment profit | 2022-09-01 → 2023-08-31 | ¥2.9bn |
| Surgel Related Productsreportable segment | depreciation | 2022-09-01 → 2023-08-31 | ¥389m |
| Surgel Related Productsreportable segment | revenue | 2022-09-01 → 2023-08-31 | ¥6.8bn |
| Surgel Related Productsreportable segment | revenue external | 2022-09-01 → 2023-08-31 | ¥6.8bn |
| Surgel Related Productsreportable segment | segment profit | 2022-09-01 → 2023-08-31 | ¥2.1bn |
| —segment total | depreciation | 2022-09-01 → 2023-08-31 | ¥1.9bn |
| —segment total | revenue | 2022-09-01 → 2023-08-31 | ¥24.5bn |
| —segment total | revenue external | 2022-09-01 → 2023-08-31 | ¥24.5bn |
| —segment total | revenue intersegment | 2022-09-01 → 2023-08-31 | ¥1m |
| —segment total | segment profit | 2022-09-01 → 2023-08-31 | ¥7.2bn |
| Dental Related Productsreportable segment | employees | at 2024-08-31 | 111 pure |
| Eyeless Needle Related Productsreportable segment | employees | at 2024-08-31 | 65 pure |
| Surgel Related Productsreportable segment | employees | at 2024-08-31 | 102 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,476
| Item | Context | Value | Unit |
|---|---|---|---|
| Number of shares held | CurrentYearInstant | 49159600 | |
| Shareholding ratio | CurrentYearInstant | 0.4990 | |
| Number of shares issued shares voting rights | CurrentYearInstant_SharesWithNoVotingRightsMember | － | |
| Number of shares issued shares voting rights | CurrentYearInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember | － | |
| Number of shares issued shares voting rights | CurrentYearInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of voting rights issued shares voting rights | CurrentYearInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of shares issued shares voting rights | CurrentYearInstant_OrdinarySharesSharesWithFullVotingRightsTreasurySharesEtcMember | 8484600 | |
| Number of shares issued shares voting rights | CurrentYearInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 98476000 | |
| Number of voting rights issued shares voting rights | CurrentYearInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 984760 | |
| Number of shares issued shares voting rights | CurrentYearInstant_OrdinarySharesSharesLessThanOneUnitMember | 42677 | |
| Number of shares issued shares voting rights | CurrentYearInstant | 107003277 | |
| Number of voting rights issued shares voting rights | CurrentYearInstant | 984760 | |
| Number of shares held in own name treasury shares etc | CurrentYearInstant_Row1Member | 8484600 | |
| Number of shares held in others names treasury shares etc | CurrentYearInstant_Row1Member | － | |
| Total number of shares held treasury shares etc | CurrentYearInstant_Row1Member | 8484600 | |
| Shareholding ratio treasury shares etc | CurrentYearInstant_Row1Member | 0.0793 | |
| Number of shares held in own name treasury shares etc | CurrentYearInstant | 8484600 | |
| Number of shares held in others names treasury shares etc | CurrentYearInstant | － | |
| Total number of shares held treasury shares etc | CurrentYearInstant | 8484600 | |
| Shareholding ratio treasury shares etc | CurrentYearInstant | 0.0793 | |
| Total amount of dividends dividends of surplus | FilingDateInstant_Row1Member | 1575000000 | JPY |
| Dividend per share dividends of surplus | FilingDateInstant_Row1Member | 16 | |
| Total amount of dividends dividends of surplus | FilingDateInstant_Row2Member | 2265000000 | JPY |
| Dividend per share dividends of surplus | FilingDateInstant_Row2Member | 23 | |
| Number of male directors and other officers | FilingDateInstant | 11 | |
| Number of female directors and other officers | FilingDateInstant | 1 | |
| Ratio of female directors and other officers | FilingDateInstant | 0.083 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E02340-000WatanabeMasayaMember | 400 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E02340-000TakahashiKazuoMember | 41825 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E02340-000TakaiToshihideMember | 51000 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E02340-000YanoTatsushiMember | 2700 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E02340-000MoriyamaYukikoMember | 200 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E02340-000MitsusadaYosukeMember | 1500 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E02340-000MatsuiYukioMember | － | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant | 97625 | |
| Number of shares held ordinary shares information about executive directors | FilingDateInstant_jpcrp030000-asr_E02340-000SaitoMasahikoMember | 37904 | |
| Number of shares held ordinary shares information about executive directors | FilingDateInstant_jpcrp030000-asr_E02340-000WatanabeMasayaMember | 400 | |
| Number of shares held ordinary shares information about executive directors | FilingDateInstant_jpcrp030000-asr_E02340-000TakahashiKazuoMember | 41825 | |
| Number of shares held ordinary shares information about executive directors | FilingDateInstant_jpcrp030000-asr_E02340-000KuritaShuichiMember | 7596 | |
| Number of shares held ordinary shares information about executive directors | FilingDateInstant_jpcrp030000-asr_E02340-000FukumotoHideshiMember | 7460 | |
| Number of shares held ordinary shares information about executive directors | FilingDateInstant_jpcrp030000-asr_E02340-000KosakaTomomiMember | 9373 | |
| Number of shares held ordinary shares information about executive directors | FilingDateInstant_jpcrp030000-asr_E02340-000HashimotoNaohisaMember | 6719 | |
| Number of shares held ordinary shares information about executive directors | FilingDateInstant | 111277 | |
| Audit fees reporting company | Prior1YearDuration | 37000000 | JPY |
| Non audit fees reporting company | Prior1YearDuration | － | JPY |
| Audit fees reporting company | CurrentYearDuration | 45000000 | JPY |
| Non audit fees reporting company | CurrentYearDuration | － | JPY |
| Audit fees consolidated subsidiaries | Prior1YearDuration | － | JPY |
| Non audit fees consolidated subsidiaries | Prior1YearDuration | － | JPY |
| Audit fees consolidated subsidiaries | CurrentYearDuration | － | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |